COMMUNIQUÉS West-GlobeNewswire

NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY - 30 JUNE 2017 (UNAUDITED)

16/08/2017 - 08:00

Company announcement, Helsinki, 16 August 2017 at 9:00 am Company Highlights, January - June 2017 Patient enrolment for Nexstim's supplementary Phase III Trial in Stroke Rehabilitation (E-FIT) using its NBT ® system is [...]

Ascom Myco and Koutio Médipôle optimize care communications and responsiveness

16/08/2017 - 08:00

Enabled by the Ascom Myco smart device, the new Koutio Médipôle is realizing improved care delivery through seamless information flow from the point of care to anywhere. BAAR, Switzerland, Aug. 16, 2017 (GLOBE NEWSWIRE [...]

New ThromboGenics' Ocriplasmin Clinical and Health Economic Data Presented at ASRS 2017 Annual Scientific Meeting in Boston

16/08/2017 - 07:30

Leuven, Belgium, 16 August 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for diabetic eye disease, announced today that further ocriplasmin clinical and health [...]

Curetis Announces Management Board Changes

16/08/2017 - 07:13

Curetis Announces Management Board Changes - New roles for Andreas Boos, Chris Bernard and Dr. Achim Plum Amsterdam, the Netherlands, and Holzgerlingen, Germany, August 16, 2017; published at 7 am CET -- Curetis N.V. ( [...]

MDxHealth Notice of January-June 2017 Financial Results

16/08/2017 - 07:00

COMPANY ANNOUNCEMENT / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, August 16, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that it will release its financial [...]

Avis de publication des résultats financiers de MDxHealth pour janvier-juin 2017

16/08/2017 - 07:00

Annonce d'entreprise / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CALIFORNIE et HERSTAL, BELGIQUE - 07:00 CEST, le 16 août, 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé la publication le jeudi 31 [...]

H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business

16/08/2017 - 07:00

Financial results for the first half of 2017 Order entry of CHF 291.2 million (H1 2016: CHF 250.6 million) Growth of 16.7% in local currencies or 16.2% in Swiss francs Double-digit increase in both business segments [...]

La société NGX Bio a réuni 3 millions $ pour financer sa croissance sur le marché du séquençage de l'ADN

16/08/2017 - 01:57

SAN FRANCISCO, le 15 août 2017 (GLOBE NEWSWIRE) - NGX Bio, Inc., ( www.NGXbio.com ), leader du marché dans la prestation de services en ligne dans le domaine du séquençage de l'ADN, a annoncé la finalisation d'une levée [...]

ObsEva Reports Second Quarter 2017 Financial Results and Provides Business Update

15/08/2017 - 22:05

- Patient Enrollment Progressing for late stage clinical programs in Assisted Reproductive Technology, Uterine Fibroids, and Endometriosis - Geneva, Switzerland and Boston, MA - August 15, 2017 - ObsEva SA (NASDAQ: OBSV [...]

Prothena to Present New Research on Cardiac Biomarker NT-proBNP in AL Amyloidosis at HFSA Annual Meeting

15/08/2017 - 22:05

Preclinical Research Demonstrating a Relationship Between Amyloid Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP and Health-related Quality of Life [...]

Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2018

15/08/2017 - 18:00

DUBLIN - August 15, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the first quarter fiscal year 2018 on Tuesday, August 22, 2017. A news release will be issued at [...]

NGX Bio Raises $3 Million to Fund Growth of Its DNA Sequencing Marketplace

15/08/2017 - 17:00

SAN FRANCISCO, Aug. 15, 2017 (GLOBE NEWSWIRE) -- NGX Bio, Inc., ( www.NGXbio.com ) the premier marketplace for online DNA sequencing services, announced it has closed a $3 million funding round. The round was led by 180 [...]

Overallotment option of 15% has been exercised

15/08/2017 - 15:19

Company announcement - No. 37/2017 Overallotment option of 15% has been exercised The 15% overallotment option in connection with Zealand Pharma A/S' initial public offering of American Depositary Shares on the Nasdaq [...]

End of stabilization period

15/08/2017 - 15:17

Company announcement - No. 36/2017 End of stabilization period Zealand Pharma A/S has today received notification regarding the end of the stabilization period Copenhagen, August 15, 2017 - With reference to company [...]

Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension

15/08/2017 - 14:30

MOUNTAIN VIEW, Calif., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces that the [...]

Bolton NHS Foundation Trust selects Allscripts to enhance care and clinical engagement

15/08/2017 - 09:00

U.K. Trust launches Allscripts Sunrise(TM) EPR to enable integrated patient record BOLTON, United Kingdom, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Bolton NHS Foundation Trust has selected Allscripts Sunrise Electronic Patient [...]

Curetis Partners with Biotest to support academic PEPPER Pentaglobin® Peritonitis Trial with Unyvero IAI Application

15/08/2017 - 08:13

Curetis Partners with Biotest to support academic PEPPER Pentaglobin ® Peritonitis Trial with Unyvero IAI Application - Trial sponsored by University Clinic RWTH Aachen investigates personalized treatment approaches [...]

Changes in Novo Nordisk Executive Management

15/08/2017 - 08:00

Bagsværd, Denmark, 15 August 2017 - Novo Nordisk A/S today announced two changes to its Executive Management team. As of 1 October, Camilla Sylvest, senior vice president in charge of Novo Nordisk's operations in Region [...]

Immunicum AB (publ) Announces Last Patient Last Visit in the Ongoing Phase I/II Hepatocellular Carcinoma Study

15/08/2017 - 08:00

Press Release 15 August 2017 Immunicum AB (publ) Announces Last Patient Last Visit in the Ongoing Phase I/II Hepatocellular Carcinoma Study Immunicum AB (publ; First North Premier: IMMU.ST), a biopharmaceutical company [...]